Indices of the Scleroderma Assessment Questionnaire (SAQ) can be used to demonstrate change in patients with systemic sclerosis over time

Joint Bone Spine

Volumn 75, Issue 3, 2008, Pages 286-290

  Ostojic, Predrag ^a   Damjanov, Nemanja ^a  

^a Dedinje Cardiovascular Institute   (Serbia)

Author keywords

Disease status; Functional ability; Questionnaire; Systemic sclerosis

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR SYSTEM; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; FOLLOW UP; GASTROINTESTINAL TRACT; HEALTH STATUS; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL SYSTEM; PATIENT ASSESSMENT; QUESTIONNAIRE; SCLERODERMA ASSESSMENT QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SCLERODERMA, SYSTEMIC;

EID: 43049148974     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.06.014     Document Type: Article

References (14)

1. Valentini G., Della Rosa A., Bombardieri S., et al. European multicentre study to define disease activity criteria for systemic sclerosis.* II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60 (2001) 592-598
2. Medsger Jr. T.A., Silman A.J., Steen V.D., et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26 (1999) 2159-2167
3. Clements P.J., Weng K.W., Hurwitz E.L., et al. Correlates of the disability index of the Health Assessment Questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum 42 (1999) 2372-2380
4. Poole J.L., and Steen V.D. The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 4 (1991) 27-31
5. Steen V., and Medsger Jr. T.A. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 40 (1997) 1984-1991
6. Rouf J., Brühlmann P., Michel A., et al. Development and validation of a self-administered systemic sclerosis questionnaire (SySQ). Rheumatology 38 (1999) 535-542
7. Silman A., Akesson A., Newman J., et al. Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument. J Rheumatol 25 (1988) 79-83
8. Georges C., Chassany O., Mouthon L., et al. Validation of French Version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol 24 (2005) 3-10
9. Ostojic P., and Damjanov N. The Scleroderma Assessment Questionnaire (SAQ): a new self-assessment questionnaire for evaluation of disease status in patients with systemic sclerosis. Z Rheumatol 65 (2006) 168-175
10. Mercado U., Arroyo de Anda R., Avenduo L., et al. Metoclopramide response in patients with early diffuse systemic sclerosis. Effect on esophageal motility abnormalities. Clin Exp Rheumatol 23 (2005) 685-688
11. Johnson D.A., Drane W.E., Curran J., et al. Metoclopramide response in patients with progressive systemic sclerosis. Effect on esophageal and gastric abnormalities. Arch Intern Med 147 (1987) 1597-1601
12. Drane W.E., Karvelis K., Johnson D.A., et al. Scintigraphic detection of metoclopramide esophageal stimulation in progressive systemic sclerosis. J Nucl Med 28 (1987) 1040
13. Ferraz M.B., Quaresma M.R., Aquino L.R., et al. Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J Rheumatol 17 (1990) 1022-1024
14. Zivkovic N., Petrovic R., and Miliv V. Assessment of the value of different pain measurement scales in rheumatoid arthritis patients. Acta Rheum Belgrad 26 2 (1996) 49-52